Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8248790 | 8486008 | I | 8248790-4 | 20120301 | 20120324 | 20120331 | EXP | PHEH2012US006752 | NOVARTIS PHARMACEUTICAL CORPORATION | 68 | YR | F | Y | 20120330 | MD | UNITED STATES |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8248790 | 1019282902 | PS | GILENYA | 1 | ORAL | 0.5 MG, QD | 022527 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 8248790 | 1019282902 | MULTIPLE SCLEROSIS |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 8248790 | OT |
| 8248790 | HO |
| 8248790 | LT |
Reactions reported
| Event ID | PT |
|---|---|
| 8248790 | JC VIRUS TEST POSITIVE |
| 8248790 | PNEUMONIA |
| 8248790 | CONVULSION |
| 8248790 | POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
| 8248790 | URINARY TRACT INFECTION |
| 8248790 | CENTRAL NERVOUS SYSTEM LESION |
| 8248790 | INCOHERENT |
| 8248790 | MULTIPLE SCLEROSIS |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 8248790 | 1019282902 | 20120301 |